Jci_page_head_homepage_01 Jci_page_head_homepage_02
Shinichi Yoshimura, Tetsuyuki Teramoto, Michael J. Whalen, Michael C. Irizarry, Yasushi Takagi, Jianhua Qiu, Jun Harada, Christian Waeber, Xandra O. Breakefield, Michael A. Moskowitz
Published in Volume 112, Issue 8
J Clin Invest. 2003; 112(8):1202–1210 doi:10.1172/JCI16618
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

Quantification of volume loss of GCL in C57BL/6 mice injected with HSV-1/mFGF-2 or HSV-1/empty after CCI. Mice were injected with HSV-1/mFGF-2 or HSV-1/empty 1 hour after CCI and analyzed on day 35. The volume in the ipsilateral GCL was expressed as a percentage of volume occupied by the corresponding region in the contralateral DG (see Methods). HSV-1/mFGF-2 (white bars) attenuated the volume loss compared with treatment with HSV-1/empty (black bars). P < 0.05 compared with mice (HSV-1/empty) on day 9 after CCI. *P < 0.05 compared with HSV-1/empty group on day 35 after injury (n = 6 per group).